SEC Form 4 · accession 0001437749-17-021101
GeoVax Labs, Inc. · GOVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dean G Kollintzas
Director
Period of report
Dec 20, 2017
Accepted (ET)
Dec 22, 2017 · 11:25 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000832489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $0.05 | Dec 20, 2017 | A | 170,000 | A | — | Dec 20, 2027 | Common Stock | 170,000 | 170,000 | D |
Explanation of responses
- F1Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.